AAAAAA
Results:
1-7
|
Results: 7
Authors:
TREPEL M
GROSCURTH P
MALIPIERO U
GULBINS E
DICHGANS J
WELLER M
Citation: M. Trepel et al., CHEMOSENSITIVITY OF HUMAN-MALIGNANT GLIOMA - MODULATION BY P53 GENE-TRANSFER, Journal of neuro-oncology, 39(1), 1998, pp. 19-32
Authors:
REBER U
WULLNER U
TREPEL M
BAUMGART J
SEYFRIED J
KLOCKGETHER T
DICHGANS J
WELLER M
Citation: U. Reber et al., POTENTIATION OF TREOSULFAN TOXICITY BY THE GLUTATHIONE-DEPLETING AGENT BUTHIONINE SULFOXIMINE IN HUMAN-MALIGNANT GLIOMA-CELLS - THE ROLE OFBCL-2, Biochemical pharmacology, 55(3), 1998, pp. 349-359
Authors:
WAGENKNECHT B
TREPEL M
VONDEIMLING A
GRIMMEL C
ROLLBROCKER B
HAYASHI Y
LANG F
DICHGANS J
GULBINS E
WELLER M
Citation: B. Wagenknecht et al., P53 ACCUMULATION PROMOTES DEPHOSPHORYLATION AND PROTEOLYTIC CLEAVAGE OF RETINOBLASTOMA PROTEIN IN HUMAN-MALIGNANT GLIOMA-CELLS, Cellular physiology and biochemistry, 7(6), 1997, pp. 304-311
Authors:
TREPEL M
SCHEDING S
GROSCURTH P
HORNY HP
MALIPIERO U
BRUGGER W
DICHGANS J
WELLER M
Citation: M. Trepel et al., A NEW LOOK AT THE ROLE OF P53 IN LEUKEMIA-CELL SENSITIVITY TO CHEMOTHERAPY, Leukemia, 11(11), 1997, pp. 1842-1849
Authors:
ROTH W
FONTANA A
TREPEL M
REED JC
DICHGANS J
WELLER M
Citation: W. Roth et al., IMMUNOCHEMOTHERAPY OF MALIGNANT GLIOMA - SYNERGISTIC ACTIVITY OF CD95LIGAND AND CHEMOTHERAPEUTICS, Cancer immunology and immunotherapy, 44(1), 1997, pp. 55-63
Authors:
WELLER M
TREPEL M
GRIMMEL C
SCHABET M
BREMEN D
KRAJEWSKI S
REED JC
Citation: M. Weller et al., HYPERICIN-INDUCED APOPTOSIS OF HUMAN-MALIGNANT GLIOMA-CELLS IS LIGHT-DEPENDENT, INDEPENDENT OF BCL-2 EXPRESSION, AND DOES NOT REQUIRE WILD-TYPE P53, Neurological research, 19(5), 1997, pp. 459-470
Authors:
TREPEL M
WELLER M
DICHGANS J
PETERSEN D
Citation: M. Trepel et al., VOLUNTARY FACIAL PALSY WITH A PONTINE LESION, Journal of Neurology, Neurosurgery and Psychiatry, 61(5), 1996, pp. 531-533
Risultati:
1-7
|